|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/00 | |||
| C07H 21/04 | |||
| C07K 16/28 |
| (11) | Number of the document | 3357510 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18151214.6 |
| Date of filing the European patent application | 2011-05-04 | |
| (97) | Date of publication of the European application | 2018-08-08 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-05 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 331177 P | 2010-05-04 | US |
| (72) |
WONG, Justin, US
VASQUEZ, Maximiliano, US
|
| (73) |
Five Prime Therapeutics, Inc.,
111 Oyster Point Boulevard, South San Francisco, CA 94080,
US
|
| (54) | ANTIBODIES THAT BIND CSF1R |
| ANTIBODIES THAT BIND CSF1R |